News and Events

Science Spotlight – Supporting Muscle Health and Cognitive Performance for Individuals on GLP-1 Therapies

GLP-1 receptor agonists have become a popular and effective solution for weight management and improving metabolic health. Medications like semaglutide (Ozempic®, Wegovy®, and others) are transforming how we approach obesity, type 2 diabetes, and metabolic syndrome....

CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients

CARLSBAD, CA, OCTOBER 24, 2024—CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), are pleased to announce a new distribution partnership with B&D Nutritional Ingredients, Inc., a renowned raw material distributor...

CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism

CARLSBAD, CA, AUGUST 26, 2024—Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy on September 7-10, 2024. ESPEN 2024 offers a unique platform for companies...

CarnoSyn® Brands Unveils TriBsyn™ – “The World’s First Paresthesia-Free Beta-Alanine Powder”

CARLSBAD, CA, AUGUST 7, 2024— Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn® beta-alanine and patent-pending technology...